19 Jun 2020 --- Health and wellness company TSI Group has acquired Metabolic Technologies (MTI), a research-driven company responsible for the discovery of beta-hydroxy beta-methylbutyrate (HMB), a substance naturally produced during leucine metabolism. The strategic acquisition integrates TSI’s HMB production and business development capabilities with MTI’s clinical R&D capabilities. Extended research on the benefits of TSI’s branded HMB ingredient, myHMB, in the field of sports nutrition is projected to help “a much larger base of consumers, beyond traditional sports nutrition” access HMB.
